Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fenofibrate in combination with ursodeoxycholic acid for primary biliary cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University of Miami | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: WITHDRAWN